10.02.2010 • News

Celanese Profit Beats Street; Revenue Up 8%

Celanese posted a better-than-expected fourth-quarter profit as demand for its chemical products increased, pushing revenue higher. The company reported net income of $5 million, or 2 cents per share, compared with a year-earlier loss of $155 million, or $1.09 per share.

Excluding one-time items, including restructuring charges, Celanese posted profit of 50 cents per share. Analysts expected earnings of 47 cents per share, according to Thomson Reuters I/B/E/S. Revenue rose 8 percent to $1.39 billion. Analysts expected $1.25 billion.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read